CO4700033A1 - Preparados de liberacion controlada a base de una sal pota- sica alcalinizante - Google Patents

Preparados de liberacion controlada a base de una sal pota- sica alcalinizante

Info

Publication number
CO4700033A1
CO4700033A1 CO96029255A CO96029255A CO4700033A1 CO 4700033 A1 CO4700033 A1 CO 4700033A1 CO 96029255 A CO96029255 A CO 96029255A CO 96029255 A CO96029255 A CO 96029255A CO 4700033 A1 CO4700033 A1 CO 4700033A1
Authority
CO
Colombia
Prior art keywords
dosage form
crystals
coating
potassium salt
salt
Prior art date
Application number
CO96029255A
Other languages
English (en)
Inventor
John J Steinke
Marder Herman
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of CO4700033A1 publication Critical patent/CO4700033A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

. Un preparado de liberación controlada en múltiples partículasincorpora una sal alcalinizante de potasio como ingrediente activo y adecuado para producir una forma de dosificación farmacéutica para administración oral, caracterizado porque comprende: (a) una multiplicidad de monocristales de la sal alcalinizante de potasio, teniendo los cristales relaciones de aspecto inferiores 3:1, tamaños de partículas superiores a 500, un tamaño medio de partícula en peso superior a 700 y un área superficial B.E.T. inferior a 0,015 m /gramo;(b) un revestimiento sobre cada uno de los cristales de sal alcalinizante potasio, que comprende un material formador de película y una cera hidrófoba compatibles, siendo la cera hidrófoba y el material de película insolubles en agua, solubles en el mismo disolvente y miscibles entre sí en la solución utilizada para formar el revestimiento; yformando una membrana permeable fuerte, pero fina, en el revestimiento seco; siendo capaces los cristales revestidos de conformarse en tabletas en una forma de dosificación en donde la sal alcalinizante de potasio constituye al menos el 75% de la forma de dosificación en tabletas.
CO96029255A 1995-06-06 1996-06-06 Preparados de liberacion controlada a base de una sal pota- sica alcalinizante CO4700033A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/472,693 US5674529A (en) 1995-06-06 1995-06-06 Alkalinizing potassium salt controlled release preparations

Publications (1)

Publication Number Publication Date
CO4700033A1 true CO4700033A1 (es) 1998-12-29

Family

ID=23876566

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96029255A CO4700033A1 (es) 1995-06-06 1996-06-06 Preparados de liberacion controlada a base de una sal pota- sica alcalinizante

Country Status (18)

Country Link
US (1) US5674529A (es)
EP (1) EP0840598A4 (es)
JP (1) JPH11506778A (es)
KR (1) KR19990022537A (es)
CN (1) CN1106837C (es)
AR (1) AR003131A1 (es)
AU (1) AU698784B2 (es)
BR (1) BR9608392A (es)
CA (1) CA2223281A1 (es)
CO (1) CO4700033A1 (es)
CZ (1) CZ288129B6 (es)
HU (1) HUP9900856A2 (es)
NO (1) NO312815B1 (es)
NZ (1) NZ310138A (es)
PL (1) PL323939A1 (es)
SK (1) SK167797A3 (es)
WO (1) WO1996039127A1 (es)
ZA (1) ZA964427B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
US20030157247A1 (en) * 2000-06-14 2003-08-21 Yoshiro Chikami Method for producing coated bioactive granule
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
CA2480824A1 (fr) 2002-04-09 2003-10-16 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2004091614A2 (en) * 2003-04-14 2004-10-28 Teva Pharmaceutical Industries Ltd. Stabilized amlodipine maleate formations
RU2473332C2 (ru) * 2007-10-12 2013-01-27 Ферринг Интернэшнл Сентер С.А. Способ изготовления фармацевтического продукта, содержащего лимонную кислоту, оксид магния, бикарбонат калия и пикосульфат натрия, фармацевтические композиции, содержащие гранулы, полученные таким способом, и промежуточное соединение
FR2967578B1 (fr) * 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
AU571312B2 (en) * 1984-02-10 1988-04-14 Nycomed Danmark A/S Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
CA1270765A (en) * 1985-02-19 1990-06-26 Charles Hsiao Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
JP2843146B2 (ja) * 1988-10-21 1999-01-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 骨粗しょう症の治療
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5445805A (en) * 1993-05-06 1995-08-29 Church & Dwight Co., Inc. Large potassium bicarbonate crystals and process for the preparation thereof

Also Published As

Publication number Publication date
CA2223281A1 (en) 1996-12-12
HUP9900856A2 (hu) 1999-08-30
CN1106837C (zh) 2003-04-30
CZ288129B6 (cs) 2001-04-11
NO975567L (no) 1998-02-05
US5674529A (en) 1997-10-07
AU6047396A (en) 1996-12-24
EP0840598A4 (en) 2001-08-29
AU698784B2 (en) 1998-11-05
CN1187121A (zh) 1998-07-08
NO312815B1 (no) 2002-07-08
ZA964427B (en) 1997-02-24
BR9608392A (pt) 1999-11-30
KR19990022537A (ko) 1999-03-25
PL323939A1 (en) 1998-04-27
NZ310138A (en) 1999-04-29
NO975567D0 (no) 1997-12-03
EP0840598A1 (en) 1998-05-13
WO1996039127A1 (en) 1996-12-12
AR003131A1 (es) 1998-07-08
CZ389297A3 (cs) 1998-06-17
JPH11506778A (ja) 1999-06-15
SK167797A3 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
CO5160287A1 (es) Formulacion de liberacion controlada de divalproex sodico
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
CO4700033A1 (es) Preparados de liberacion controlada a base de una sal pota- sica alcalinizante
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
AR066313A2 (es) Una formulacion de liberacion controlada de galantamina, una forma farmaceutica de dosificacion, un proceso para la preparacion de dicha formulacion, y el uso de dicha formulacion para la manufactura de un medicamento
IT1276689B1 (it) Forma farmaceutica solida ad uso orale
BR9609663A (pt) Formulações para desprendimento controlado de medicamentos fracamente soluveis
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
AU4121297A (en) Galenic form with extended release of milnacipran
RU97115570A (ru) Применение неорганических аэрогелей в фармации
ATE279186T1 (de) Retardierte darreichungsform enthaltend tramadolsaccharinat
PT94898B (pt) Processo para a preparacao de pastilhas medicamentosas de mascar rotogranuladas e cobertas por revestimento para mascarar o sabor
PE20001414A1 (es) Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad
ES2547722T3 (es) Formulación de liberación controlada para la administración oral de metformina
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
EA200501901A1 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путём
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
JP2005526061A5 (es)
JP2003518486A5 (es)
WO2016092387A1 (en) Powder combinations to get in-situ sponge/patch -gel/sol formulations
ES2057021T3 (es) Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.
MX9301189A (es) Forma de administracion farmaceutica, solida, finamente dividida, para administracion oral, disuelta o suspendida en un liquido farmaceuticamente aceptable y procedimiento para su preparacion.
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm